HTFL insider trades & Congress trades
Heartflow, Inc.: public insider filings and Congress disclosures, in one place.
Bourse has recorded 18 open-market insider transactions in Heartflow, Inc. (HTFL) (0 purchases with code P and 18 sales with code S), the most recent on October 22, 2026.
In the last 90 days: 0 purchases by 0 insiders ($0) and 18 sales by 3 ($15.5M).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Oct 22, 2026 | Rogers Campbell | Chief Medical Officer | Sell | 23,933 | $55.01 | $1.32M | – |
| Oct 12, 2026 | Farquhar John C.M. | Chief Executive Officer | Sell | 38,900 | $49.57 | $1.93M | – |
| Sep 18, 2026 | Verghese Vikram | Chief Financial Officer | Sell | 16,766 | $50.75 | $851K | – |
| Sep 18, 2026 | Rogers Campbell | Chief Medical Officer | Sell | 19,682 | $50.15 | $987K | +0.1% |
| Sep 17, 2026 | Verghese Vikram | Chief Financial Officer | Sell | 7,579 | $50.11 | $380K | +0.0% |
| Sep 15, 2026 | Verghese Vikram | Chief Financial Officer | Sell | 668 | $50.01 | $33K | +0.0% |
| Sep 14, 2026 | Verghese Vikram | Chief Financial Officer | Sell | 4,593 | $50.24 | $231K | +0.0% |
| Sep 11, 2026 | Farquhar John C.M. | Chief Executive Officer | Sell | 3,890 | $50.00 | $195K | +0.0% |
| Sep 11, 2026 | Verghese Vikram | Chief Financial Officer | Sell | 29,714 | $50.06 | $1.49M | +0.0% |
| Sep 10, 2026 | Farquhar John C.M. | Chief Executive Officer | Sell | 35,010 | $46.42 | $1.63M | +0.0% |
| Sep 8, 2026 | Verghese Vikram | Chief Financial Officer | Sell | 6,640 | $50.03 | $332K | +0.1% |
| Sep 3, 2026 | Verghese Vikram | Chief Financial Officer | Sell | 27,540 | $49.69 | $1.37M | +0.0% |
| Sep 2, 2026 | Verghese Vikram | Chief Financial Officer | Sell | 5,876 | $50.60 | $297K | +0.0% |
| Aug 21, 2026 | Farquhar John C.M. | Chief Executive Officer | Sell | 27,230 | $50.00 | $1.36M | −0.0% |
| Aug 18, 2026 | Farquhar John C.M. | Chief Executive Officer | Sell | 32,676 | $45.00 | $1.47M | +0.1% |
| Aug 17, 2026 | Rogers Campbell | Chief Medical Officer | Sell | 9,219 | $41.23 | $380K | +0.1% |
| Aug 14, 2026 | Farquhar John C.M. | Chief Executive Officer | Sell | 15,560 | $39.06 | $608K | +0.1% |
| Aug 10, 2026 | Farquhar John C.M. | Chief Executive Officer | Sell | 22,562 | $28.31 | $639K | +0.7% |
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.